Modeling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.

被引：0

作者：

Das Thakur, Meghna ^{[1
]}

Fisher, Rosalie ^{[2
]}

Salangsang, Fernando ^{[1
]}

Landman, Allison ^{[3
]}

Sellers, William ^{[4
]}

Pryer, Nancy ^{[1
]}

Levesque, Mitchell Paul ^{[5
]}

Dummer, Reinhard ^{[5
]}

Gore, Martin ^{[2
]}

Larkin, James ^{[2
]}

McMahon, Martin ^{[3
]}

Stuart, Darrin ^{[1
]}

机构：

[1] Novartis, Emeryville, CA USA

[2] Royal Marsden Hosp, London SW3 6JJ, England

[3] UCSF, San Francisco, CA USA

[4] Novartis, Cambridge, MA USA

[5] Univ Zurich Hosp, CH-8091 Zurich, Switzerland

来源：

CANCER RESEARCH | 2013年 / 73卷 / 08期

关键词：

D O I：

10.1158/1538-7445.AM2013-LB-144

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB144

引用

页数：1

共 50 条

[1] Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Meghna Das Thakur
Fernando Salangsang
Allison S. Landman
William R. Sellers
Nancy K. Pryer
Mitchell P. Levesque
Reinhard Dummer
Martin McMahon
Darrin D. Stuart
Nature, 2013, 494 : 251 - 255
[2] Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Das Thakur, Meghna
Salangsang, Fernando
Landman, Allison S.
Sellers, William R.
Pryer, Nancy K.
Levesque, Mitchell P.
Dummer, Reinhard
McMahon, Martin
Stuart, Darrin D.
NATURE, 2013, 494 (7436) : 251 - 255
[3] Molecular modeling of drug resistance.
Chen, YZ
Gu, XL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U609 - U609
[4] Drug resistance.
J.H. Beijnen
Pharmacy World and Science, 1997, 19 (4): : 211 - 211
[5] Novel mouse model reveals strategy to delay drug resistance in melanoma
Lisa Hutchinson
Nature Reviews Clinical Oncology, 2013, 10 (3) : 123 - 123
[6] New insights into vemurafenib resistance in melanoma
Miller, Sarah
PHARMACOGENOMICS, 2012, 13 (03) : 254 - 254
[7] Early HIV treatment to forestall drug resistance
Wainberg, Mark A.
LANCET INFECTIOUS DISEASES, 2016, 16 (05): : 512 - 513
[8] Intermittent vemurafenib prevents resistance in melanoma
Nature Reviews Clinical Oncology, 2013, 10 (5) : 250 - 250
[9] VemurafenibEmergence of vemurafenib resistance in melanoma: case report
Reactions Weekly, 2017, 1650 (1) : 276 - 276
[10] Strategy to determine basis for warfarin resistance.
Bukaveckas, BL
Khan, D
Valdes, R
Linder, MW
CLINICAL CHEMISTRY, 2003, 49 (06) : A120 - A120

← 1 2 3 4 5 →